Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Nestle SA's Nestle Health Science SA And Hutchison China MediTech Ltd Completes Regulatory Approvals For Establishment Of Nutrition Science Partners Joint Venture


Friday, 12 Apr 2013 02:16am EDT 

Nestle SA's fully-owned subsidiary, Nestle Health Science SA and Hutchison China MediTech Ltd announced that all regulatory approvals required for the establishment of the 50/50 joint venture Nutrition Science Partners Limited (NSP) have been received. The purpose of NSP is to research, develop, manufacture and market worldwide medicines and nutritional products derived from botanical plant origins. NSP will focus on gastrointestinal indications and may in the future expand into the metabolic disease and brain health areas. 

Company Quote

1360.0
65.0 +5.02%
27 Feb 2015